Electronic medical records provide potential benefits and also drawbacks. Potential benefits include increased patient safety and efficiency. Potential drawbacks include newly introduced errors and diminished workflow efficiency. In the patient safety context, medication errors account for significant patient harm. Electronic prescribing (e-prescribing) offers the promise of automated drug interaction and dosage verification. In addition, the process of enabling e-prescriptions also provides access to an often unrecognized benefit, that of viewing the dispensed medication history. This information is often critical to understanding patient symptoms. Obtaining significant value from electronic medical records requires use of standardized terminology for both targeted decision support and population-based management. Further, generating documentation for a billable encounter requires usage of proper codes. The emergence of International Classification of Diseases (ICD)-10 holds promise in facilitating identification of a more precise patient code while also presenting drawbacks given its complexity. This article will focus on elements of e-prescribing and use of structured chart content, including diagnosis codes as they relate to physician office practices.
W ith the signature of President Obama in 2009, the Health Information Technology for Economic and
Clinical Health Act (HITECH) became law. The focus of HITECH was to stimulate adoption of electronic medical records and encourage creation of infrastructure to enable interoperability of medical records. The ensuing Meaningful Use subsidy program offered maximum Medicare subsidies of $44,000 for eligible providers and discharge volume-based subsidies to hospitals. These incentives and additional regulatory changes-including requirements for standardized terminology usage such as the upcoming change to ICD-10 -have impacted clinical workflow signifıcantly and will continue to do so in coming years. It is worth considering two important subjects in this context: e-prescribing and use of standardized terminology within medical records, including diagnosis coding.
E-prescribing has been deemed a worthy goal for several reasons. In particular, the improved aspects of safe prescribing and patient and physician practice convenience are especially noteworthy. In the context of prescribing safely, it is important to note that 7,000 patients die each year from prescription errors, although improved safety using electronic orders has been better demonstrated for in-patient care than for ambulatory care. 1, 2 In an oncology context in particular, patients are often especially vulnerable, and risk factors for adverse drug events are often present. Efforts are underway to improve systems and approaches designed to minimize preventable adverse drug events. 3 Systems that can mitigate these risks are highly desirable, and e-prescribing, implemented with decision support, can mitigate some of these risks. 4 Access to past prescriptions from other practices, a potentially unappreciated benefıt, may follow when e-prescribing is fully implemented. Of note, there are freestanding e-prescribing solutions apart from an EHR in which selected criteria for isolated e-prescribing incentives may be met outside of meeting full Meaningful Use criteria. However, to realize the full benefıts of e-prescribing and increased benefıts from a patient safety perspective in the future, incorporating e-prescribing within a fully functional EHR is required. Within this scenario, consider the case of a patient who is completely new to a practice. Further, assume health information exchanges (HIEs) are not fully functional in the community, which is often the case given fınancial impediments to successful ongoing HIE business models. 5 Then in this case, one would presume the medication section for a new patient record would be blank. However, if a practice subscribes to the SureScripts Medication History service, a list of dispensed medications drawn from community pharmacies and the claims histories from payers and pharmacy benefıt managers appear populated with medication names and dates. At the present time the "sig" information (e.g., one tablet daily) is not yet populated given lack of requirements for discrete data elements from all source systems; however, the unit dose of a medication and the number of doses dispensed is available. Thus, in practice, the regimen may often be inferred. Further, EHR vendors now routinely provide the ability to "convert" these pharmacy-processed prescriptions into the "home medications" section of medical records. Although some manual entry to populate the sig information is required, this initial list may provide a critical starting point when patients are not completely sure of their medications.
There are several important limitations of the currently accepted system of e-prescribing. It is possible that the dose may have changed since the pharmacy processed the prescription. For example, the physician may have told the patient to take one tablet instead of two as had been dispensed, or, in fact, the medication may have been stopped entirely. An additional important limitation is that some items may be lacking for some patient groups. For example, some state Medicaid systems do not share prescription information with the Surescripts network. Further, if a patient were to pay cash and not process the transaction through a pharmacy benefıt manager, the medication may not appear within the list. Another important note is that patients may, at times, be surprised that medication lists are already available to the physician. An additional limitation is that at the time of e-prescribing, the specifıc pharmacy must be designated. Although this enables prescriptions to be picked up on a patient's way home from a physician appointment, many patients prefer to price shop among a number of pharmacies. A system that provided for holding prescriptions in abeyance until a pharmacy was selected by the patient could address this limitation. Given this limitation, though, patients may still prefer paper-based prescriptions to allow for price shopping comparisons.
The linkage from the EHR to the Surescripts medication history occurs through the patient's insurance information, which includes payer and/or a designated pharmacy benefıt manager. This linkage provides additional workflow benefıts to physicians and convenience benefıts to patients. The practice workflow benefıts ensue in that patients will be less likely to call back asking for a less expensive alternative medication. Guidance to the physician occurs during the process of e-prescribing in which formulary designations specifıc to the patient's coverage appear and facilitate the optimally chosen medication from a fınancial perspective when effıcacy factors are equivalent. Physicians, though, who may be accustomed to prescribing just one or two drugs within a given class of medications may need to become more familiar with a wider array of alternatives. From a patient perspective, there would thus be less often a need to request the pharmacist call back to request a lower priced alternative since the patient's physician would have this information during the initial prescribing process.
Proceeding along the ambulatory practice workflow for e-prescribing, there are several clear patient safety improvements that become possible with e-prescribing. These include context-specifıc warnings for weight-based dosing, renal function-based dosing, drug-drug interactions, drugallergy interactions, drug-problem list interactions, and guidance for potentially indicated but not yet prescribed medications. However, at the current state of medication prescribing decision support, it is important to realize that the decision support is neither comprehensive nor always applicable to given patient care scenarios. In fact, it is even possible to introduce new errors of a type never seen with paper-based prescribing. An example here would be when a physician cannot fınd an order with the specifıc preferred regimen listed as an available option and then orders something related and includes a free text comment to override the order details. 6 Unfortunately, this approach introduces substantial risk that the comments will be ignored and the unintended order processed instead. 7 Given the potential benefıts, a Medical Electronic Prescribing Incentive Program began January 1, 2009. This program, mandated through legislation, has begun to issue payment penalties since January 2013. The enrollment requirements are relatively simple and include use of a certifıed eRx system with reports on how often eRx is being used for prescriptions. Report metrics are then assessed relative to the specifıc criteria applicable to the reporting period and appear on the Centers for Medicare and Medicaid Services website. For example, the eRx requirements specify that at least 10% of Medicare Part B charges consist of codes specifıed in the eRx measure. Further, multiple reporting avenues exist. These include use of the eRx measure on Medicare Part B claims, participation in a qualifıed registry of patients, or submission directly from a qualifıed EHR or through use of a "qualifıed data submission vendor" as an intermediary. Further, a group practice reporting option would allow aggregate reporting. Details for both e-prescribing and Meaningful Use criteria continue to evolve. Key websites to monitor are listed in Table 1 .
Given these potential benefıts and drawbacks, it would be prudent for practices to set a series of goals to maximize the value of the workflow changes required by e-prescribing. Table  2 lists a few example options. To ensure realization of potential benefıts, practices should set specifıc goals. In addition,
KEY POINTS
⅐ Electronic prescribing offers financial incentives and patient safety benefits. ⅐ Usage of the dispensed medication history for patients may improve medication safety. ⅐ Use of structured terminology facilitates quality metrics and decision support. ⅐ Claim transmission using ICD-10 is required starting October 1, 2014.
TABLE 1. Electronic Prescribing and Meaningful Use Incentive Websites
approaches to maximize effıciency, such as setting pharmacy "favorites" in the system for nearby pharmacies would likely be a signifıcant timesaver. For electronic medical records to yield signifıcant benefıts across a population of patients, functionality to cluster similar patients and identify key clinical events and any outliers is required to ensure all patients receive a care standard. In this context, tracking variables such as diagnoses, medications, and test results in a consistent manner is required. To exchange clinical information across practice sites and track services provided and adherence to quality-of-care standards, consistent documentation schemes are required with specifıc values that may be compared and exchanged within and across practice sites. Specifıc terminologies exist across these various clinical dimensions. In the context of medications, many proprietary terminologies exist among vendors of medication content for medical record systems. RXNorm, however, is an accepted normalized list of drugs (e.g., First Databank, Micromedex, MediSpan, Gold Standard, and Multum) mapping across all proprietary references. This mapping may then facilitate both information exchange and tracking for quality measures. The National Provider Identifıer identifying specifıc physicians is another example of standardization allowing for transactions and reporting. In another example of standardization of key clinical record events, collaboration among the Offıce of the Surgeon General and the National Human Genome Research Institute has led to the formation of an online family history tool for submitting and tracking these clinical elements (https:// familyhistory.hhs.gov). In addition, for the problem list, Meaningful Use requirements specify SNOMED CT should be used, and certifıed EHR systems now incorporate this mapping either explicitly or as the default problem list terminology. Of note, the terminology used for diagnosis codes and therefore for billing purposes and various quality measures is now changing from ICD-9 to ICD-10. One might inquire why not switch from ICD-9 directly to SNOMED CT for billing if it is already in use for problem lists. As it happens, a transition from ICD-9 to ICD-10, despite the substantial changes listed in part below, will be much easier for systems and coding personnel to learn to use given similar design and implementation context. Further, for claims processing to occur, the transition to ICD-10 is now mandated for October 1, 2014, as part of the HIPAA code set.
To clarify the distinction between problem lists and diagnoses as typically used within electronic medical records, problem lists refer to ongoing medical issues, whereas diagnosis codes refer to the conditions managed during a given encounter, such as an outpatient visit. The conversion from ICD-9 to ICD-10 will greatly increase the number of available codes. Although many differences are accounted for by laterality (left vs. right), many new concepts also appear. These additional concepts will better address coverage for conditions and authorization for services, better ensure referral requirements are met, and assist with claims adjudication. Further, the enhanced specifıcity of the ICD-10 codes can better ensure quality measures are tracked accurately, which is important given a continued emphasis on pay for performance incentives. For example, ICD-10 has the potential to better identify coded patients for matching to quality-based metrics across a practice to ensure eligible patients receive appropriate health maintenance interventions and that the ineligible patients are appropriately excluded. Case mix adjustment is thought to become more accurate with this enhanced specifıcity as well.
Additional background on the ICD terminology is helpful to consider when appreciating the substantial work effort required for this code set conversion. Not only physicians and medical record systems need to adapt; practice management systems and billing processes need to be modifıed and the changes implemented overnight. ICD-9 was published in 1977 and further modifıcations were applied and effective April 1, 1989 , when ICD-9 was formalized as the code set used for Medicare reimbursement. More recently in 1996, ICD-9 codes became the established standard for almost all U.S. medical claims. Even before this in 1992, the ICD code was revised by the World Health Organization to the ICD-10 version and is now used in more than100 countries. The United States is the only industrialized country that has not yet adopted ICD-10. A clear-cut and compelling reason for adoption is that the numbering system of ICD-9 (mostly numeric with 3-5 digits) makes new concepts diffıcult or impossible to add. This has been addressed with ICD-10 (3-7 characters and alphanumeric for many additional combinations possible). Important clinical contexts are now addressed as well, for example, disease severity, specifıc fracture details, whether the service provided was an initial assessment, public health exposure scenarios, and reasons for nonadherence to regimens.
In conclusion, use of e-prescribing and adoption of a growing number of standards-such as the especially complex change to ICD-10 by October 1, 2014 -constitute signifıcant practice changes with signifıcant clinical and workflow effects. Understanding the potential benefıts of these changes will allow practices to set relevant practice-focused goals and thereby ensure not only compliance with mandated guidelines but also tangible benefıts to practice operations. References to assist with the ICD-10 conversion process are listed in Table 3 .
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